
Pharma stocks are under significant selling pressure. Here is a detailed analysis on the top worries for the sector.
The future of medicine is being shaped by a confluence of factors at play. If there are worries galore around…
This new steroid represents a significant advancement in the ophthalmic market, extending notable patient benefits, the company stated.
Explore the top 5 stocks where mutual funds raised stakes in Q3, including Axis Bank and Cipla. Discover your next…
The future seems inevitably aligned to pursuit of innovation, complex generics, tapping newer opportunities in newer therapies, newer technologies while…
Dr Hamied, as the scientist-entrepreneur is better known, is not particularly concerned about the impact of tariffs on imported medicines…
Nomura has a Buy rating on Cipla after the company’s MD reassured that the competitiveness of the Indian generics biz…
Pharma stocks plummet up to 10% amid looming US tariffs. Discover the impact!
While foreign investors have been reducing their exposure to Indian pharma, some leading domestic institutional investors (DIIs) are doing exactly…
Motilal Oswal retains Neutral on Cipla; see limited upside due to delayed niche product approvals. Learn more about the concerns…
According to the Global Burden of Disease report, the total burden of asthma in India is estimated to be 34.3…
This is the first and only non- injectable insulin to be developed for patients of both type 1 and type…
According to WHO, Anti-microbial resistance (AMR) makes infections harder to treat and makes other medical procedures and treatments – such…
Cipla share price today: The stock of Cipla has fallen more than 5.6% in the last five days and 14.2%…
The company had reported a profit of Rs. 1,177.64 crore in the year-ago period.
Umang Vohra’s leadership has transformed Cipla into a global pharmaceutical powerhouse, characterized by strategic growth and a commitment to innovation.…
In his resignation letter, MK Hamied said, “These past 47 years at Cipla have been truly a remarkable chapter in…
Cipla has a net cash balance of Rs 8,449 crore. According to Prathamesh Masdekar, Research Analyst, StoxBox, the company reported…